Willingness and preferences for long-acting injectable PrEP among US men who have sex with men: a discrete choice experiment.
Sam Wilson ColeJennifer L GlickNicola B CampoamorTravis H SanchezSupriya SarkarVani VannappagariAlex RinehartKeith RawlingsPatrick S SullivanJohn F P BridgesPublished in: BMJ open (2024)
A large proportion of MSM expressed a preference for LA-PrEP over daily oral pills. Most respondents chose LA-PrEP regardless of cost, clinic time, side effects or protection level; however, preferences varied by sociodemographics. These varied groups likely require tailored intervention strategies to achieve maximum LA-PrEP uptake and persistence.